| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.023 | 0.9 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |